Drug Information

Drug General Information
Drug ID
D0D4NS
Former ID
DNC005886
Drug Name
2-(1H-imidazo[4,5-c]pyridin-2-yl)quinoxaline
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527933]
Formula
C14H9N5
Canonical SMILES
C1=CC=C2C(=C1)N=CC(=N2)C3=NC4=C(N3)C=NC=C4
InChI
1S/C14H9N5/c1-2-4-10-9(3-1)16-8-13(17-10)14-18-11-5-6-15-7-12(11)19-14/h1-8H,(H,18,19)
InChIKey
UYUCQGUDIHPICB-UHFFFAOYSA-N
PubChem Compound ID
11536096
Target and Pathway
Target(s) Adenosine A3 receptor Target Info Inhibitor [527933]
Reactome Adenosine P1 receptors
G alpha (i) signalling events
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
GPCRs, Other
References
Ref 527933J Med Chem. 2005 Dec 29;48(26):8253-60.2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database searching.
Ref 527933J Med Chem. 2005 Dec 29;48(26):8253-60.2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database searching.